Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
TruBridge ( (TBRG) ) just unveiled an announcement.
On November 25, 2025, TruBridge entered into an Amended and Restated Credit Agreement, increasing its revolving credit facility to $180 million and its term loan facility to $70 million. The agreement, which extends the maturity date to November 2030, enhances TruBridge’s financial flexibility and positions the company for future growth, as stated by CFO Vinay Bassi. This move reflects TruBridge’s disciplined capital allocation strategy aimed at delivering higher value for stakeholders.
The most recent analyst rating on (TBRG) stock is a Hold with a $23.50 price target. To see the full list of analyst forecasts on TruBridge stock, see the TBRG Stock Forecast page.
Spark’s Take on TBRG Stock
According to Spark, TipRanks’ AI Analyst, TBRG is a Neutral.
TruBridge’s strong revenue growth and cash flow improvements are significant positives. However, profitability challenges and high valuation metrics pose risks. The earnings call provided optimistic guidance, but concerns about bookings and revenue growth in certain areas remain.
To see Spark’s full report on TBRG stock, click here.
More about TruBridge
TruBridge is a leading provider of revenue cycle management and healthcare technology solutions, primarily serving rural and community healthcare organizations. With over 45 years of experience and a client base of more than 1,500 nationwide, TruBridge offers services including revenue cycle management, electronic health records, and analytics, all tailored to the needs of rural and community healthcare providers.
Average Trading Volume: 96,004
Technical Sentiment Signal: Buy
Current Market Cap: $329.6M
Learn more about TBRG stock on TipRanks’ Stock Analysis page.